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Abstract
We present a model of articular cartilage lesion formation to simu-
late the effects of cyclic loading. This model extends and modifies the
reaction-diffusion-delay model by Graham et al. [20] for the spread of
a lesion formed though a single traumatic event. Our model represents
“implicitly” the effects of loading, meaning through a cyclic sink term
in the equations for live cells.
Our model forms the basis for in silico studies of cartilage damage
relevant to questions in osteoarthritis, for example, that may not be
easily answered through in vivo or in vitro studies.
Computational results are presented that indicate the impact of
differing levels of EPO on articular cartilage lesion abatement.
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1 Introduction
Cartilage is a tissue that thrives in a mechanically-active environment and
has been well established to be biologically responsive to physical stimuli.
The effect of dynamic loads on articular cartilage is partly of interest because
periodic changes in loading profiles are physiological (e.g., walking, running,
etc.) and pertinent to cartilage health and disease progression.
Articular cartilage that lines the surfaces of lower extremity joints in hu-
mans is routinely exposed to dynamic contact stresses in the 1-5 megapascal
range [16]. At frequencies and rates commonly encountered in activities of
daily life, stress levels in this range are not only tolerated by cartilage, but
are necessary for long-term stability [1]. On the other hand, stresses much
above 5 MPa, or stresses delivered outside physiologic norms of frequency or
rate, can lead to progressive cartilage degeneration, a hallmark of osteoarthri-
tis (OA) [25]. These observations have focused OA research on the cellular
and molecular basis of cartilage mechano-responses. Although a great deal
of progress has been made in understanding short-term responses at the tis-
sue level, it is still unclear how these processes unfold to cause the slowly
developing, organ-wide breakdown that occurs in osteoarthritic joints. As a
result, though mechanical stresses probably play a decisive role in many cases
of OA, there are currently no therapies targeting biologic mechanoresponses.
While the chronic effects of over- or under-loading can be studied in in
vivo models, the actual stresses on cartilage in most experimental animals
are a matter of conjecture and difficult to precisely control. In contrast,
stresses can be closely monitored and controlled in in vitro systems, but
only short-term responses can be studied due to culture-related instability.
These limitations leave a knowledge gap that is unlikely to be bridged by
further experimental work. However, it may still be possible to extrapolate
from short term in vitro data to OA-relevant time frames using in silico
models [20, 31]. Here we describe advanced biomathematical models that
draw on the wealth of knowledge of chondrocyte mechanotransduction to
portray realistically cartilage stress responses.
Articular cartilage response to mechanical loading is viscoelastic, largely
due to the interaction between the solid and fluid phases of its composition.
To this end, cartilage is described as a biphasic material and is generally
studied as a mixture of an elastic solid and interstitial fluid. The diffusive
momentum exchange between the two phases regulates matrix deformation
(via fluid exudation) when mechanical stimulus is imposed.
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In this investigation, we attempt to extend and modify a reaction-diffusion-
delay model of cartilage lesion formation [20] by adding features of the linear
biphasic theory to simulate cyclic compressive loading. The governing equa-
tions of this model would be able to predict displacement of the solid matrix
of the tissue (referred to as tissue strain) when a cyclic loading waveform is
applied. As opposed to a single blunt impact injury (as was the case in [20]
and explored more fully in [19]), the objective of this study is to simulate
cartilage response to injurious cyclic compressive loading.
Physiological cyclic loading generally produces tissue deformations of less
than 20%, which are not considered to cause any meaningful destruction.
The underlying criterion in this model is that chondrocytes die when consol-
idated tissue strains of large magnitudes (greater than 40% of original tissue
thickness) are induced.
We make the following implicit modeling assumptions in our loading term
about the material properties of articular cartilage: it is a composite structure
with an intrinsically incompressible, porous and elastic solid phase (chondro-
cytes, collagen and proteoglycans); and the fluid phase is assumed to be
intrinsically incompressible and inviscid. Moreover, we assume cyclic load-
ing of cartilage is imposed on a known region of cartilage surrounded by
unloaded tissue. The loaded region is simplified to be a radially symmetric
one-dimensional case of cyclic compression via a porous filter in a confined
configuration.
2 One-dimensional model with implicit me-
chanical loading
In articular cartilage, dynamic mechanical loads can stimulate biosynthetic
activity. Studying the environment of chondrocytes under dynamic loading
conditions can help explain this mechanic-biological phenomenon. In the
model in this section, we modify a reaction-diffusion-delay model by Graham
et al. [20]. In [20], the lesion was formed by an initial, severe traumatic event
with no further loading. In the model in this section, we assume instead that
there is no initial damage, but rather cyclic compressive loading on a small
part of the cartilage. The loading is expressed through a deformation term
in the system of partial differential equations, rather than through explicit
mechanical terms.
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We assume circular symmetry so that the system components depend only
on radius (r), time (t) and time delays (τ1, τ2). We simulate an oscillating
load on a small region near the origin (0 ≤ r ≤ 0.5 cm).
The components of our system fall into two main categories, cells and
chemicals. We also track extracellular matrix density. A schematic of the
system is presented in Figure 1. The cellular components of our system are
• C(r, t) = population density (cells per unit area) of healthy chondro-
cytes.
• ST (r, t) = population density of “catabolic” chondrocytes. Catabolic
chondrocytes have been signaled by alarmins and are capable of syn-
thesizing TNF-α and other cytokines associated with inflammation.
Healthy cells signaled by DAMPs or TNF-α enter into the catabolic
state and begin to synthesize TNF-α and produce reactive oxygen
species (ROS).
• SA(r, t) = population density of EPOR-active chondrocytes. EPOR-
active chondrocytes are cells that have been signaled by TNF-α and
express a receptor (EPOR) for EPO. It should be noted that there is a
time delay of 8-12 hours before a cell expresses the EPO receptor after
being signaled to become EPOR-active [14].
• DN(r, t) = population density of necrotic chondrocytes. Necrotic (lysing)
cells release DAMPs.
• DA(r, t) = population density of apoptotic chondrocytes. Apoptotic
cells no longer play a role in the system, and are tracked explicitly to
verify the conservation of cell quantities.
Since EPOR-active cells express a receptor for EPO, they may switch
back to the healthy state if signaled by EPO. However, as discussed in [14],
TNF-α limits production of EPO. Thus there is a balance between EPO
and TNF-α that determines the spreading behavior of cartilage lesions. The
catabolic and EPOR-active “sick” classes form the penumbra, the boundary
region between the lesion and healthy tissue. Because of the continuing role
they play in the system, we explicitly track lysing necrotic cell densities (DN).
Cells that have become apoptotic (DA) no longer play a relevant role in the
system (by definition of apoptosis). Their densities are tracked explicitly in
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the mathematical model for bookkeeping purposes and as a placeholder for
further models where cell volume fractions may be the quantities of interest.
This differs from the model in [20] where apoptotic cells were not tracked
explicitly, but were instead represented by sink terms in the equations for ST
and SA.
We assume chondrocytes in all states have negligible motility, although we
track them explicitly in space since their densities will differ as they respond
to the biochemical components of the system.
The chemical and material components of our system are
• R(r, t) = concentration of reactive oxygen species (ROS). ROS affects
the production of EPO by healthy cells.
• M(r, t) = concentration of alarmins (DAMPs). DAMPs signal healthy
cells to enter the catabolic state, which in turn produce TNF-α.
• F (r, t) = concentration of tumor necrosis factor alpha (TNF-α). TNF-
α, along with EPO, is the main driver of our system. TNF-α
– causes healthy cells to become catabolic,
– causes catabolic cells to enter the EPOR-active state [14],
– influences apoptosis of catabolic and EPOR-active cells,
– causes a chain of events that leads to the degradation of extracel-
lular matrix, which in turn increases the concentration of DAMPs
(for mathematical convenience we represent these as direct ef-
fects),
– limits the production of EPO [14].
• P (r, t) = concentration of erythropoietin (EPO). EPO causes EPOR-
active cells to return to the healthy state, and thus, in our model, is
the check on the spread of the inflammation.
• U(r, t) = density of extracellular matrix (ECM). ECM is degraded by
TNF-α, and in the process releases DAMPs.
The spatial dynamics of the system are governed by the diffusion of the
four chemical components (R, M , F , P ). The extracellular matrix, like the
chondrocytes, is assumed to have negligible motility.
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Our model equations are
∂tC(r, t) =αSA
P
λP + P
− β1C M
λM +M
H(Pc − P )
− β2C F
λF + F
H(Pc − P )− Γ(, U, r)C, (1a)
∂tST (r, t) =β1C
M
λM +M
H(Pc − P )− β2C F
λF + F
H(Pc − P )
− γST (t− τ1) F (t− τ1)
λF + F (t− τ1)
− νST F
λF + F
M
λM +M
− Γ(, U, r)ST , (1b)
∂tSA(r, t) =γST (t− τ1) F (t− τ1)
λF + F (t− τ1) − αSA
P
λP + P
− µSASA
F
λF + F
− Γ(, U, r)SA, (1c)
∂tDN(r, t) =− µDNDN + µSTST + Γ(, U, r)(C + ST + SA), (1d)
∂tDA(r, t) =µSASA
F
λF + F
+ νST
F
λF + F
M
λM +M
, (1e)
∂tU(r, t) =− δUU F
λF + F
H(Pc − P ), (1f)
∂tR(r, t) =
1
r
∂r(rDRRr)− δRR + σRST , (1g)
∂tM(r, t) =
1
r
∂r(rDMMr)− δMM + σMDN + σUU F
λF + F
, (1h)
∂tF (r, t) =
1
r
∂r(rDFFr)− δFF + σFST , (1i)
∂tP (r, t) =
1
r
∂r(rDPPr)− δPP + σPC R(t− τ2)
λR +R(t− τ2)
Λ
Λ + F
, (1j)
for t > 0 and 0 ≤ r ≤ rm where rm = 2.5 cm is the radius of our tissue
sample.
The function H(θ) is the Heaviside function. From [14] we have Pc = 1
nanomolar.
For spatial densities, we assume uniformity in the top centimeter of the
cartilage so that densities per cm3 are also densities per cm2 on the surface.
Initial conditions are C(r, t) = 105 cells/cm2, U(r, t) = 30 mg/cm2, and
ST (r, t) = SA(r, t) = DN(r, t) = DA(r, t) = R(r, 0) = M(r, 0) = F (r, 0) =
6
P (r, 0) = 0. We use homogeneous Neumann boundary conditions for the
chemical concentrations: ∂R
∂r
|r=0= ∂M∂r |r=0= ∂F∂r |r=0= ∂P∂r |r=0= 0.
2.1 The cyclic loading term
Central to our cyclic loading model is the function Γ(, U, r) that represents
the damage caused by cyclic loading. The goal of the model described in
system (1) is to give a simple, conceptual mathematical model and simulation
of the effects of cyclic loading on articular cartilage lesion formation. The
model in this section extends the model in [20] in a simple, yet still relevant
way.
To represent the effects of loading we use the function
Γ(, U, r) = −24 ln(1− 0.01p0(eKU  − e20KU )) λU
λU + U
, (2)
for 0 ≤ r ≤ rl, and Γ(, U, r) = 0 for r > rl, where rl = 0.25 cm is the radius
of the region of tissue experiencing loading. We note that Γ is non-negative.
The form of Γ in (2) is based on recent results on cell death as a function
of equilibrium strain [15]. There are some limitations to using this data, even
though it is the best available. The death rate is measured one hour after
loading; further results are needed to build a function with respect to both
strain and time. Cells may not keep dying; death may stop at some point
even if the same loading process continues.
In section 2.3 we present results for different values of the strain , which
has unit of percent.
2.2 Parameterization
The dependence of Γ on ECM density U means that our equation for U
is relevant to cell death. We assume that ECM is only degraded by the
effects of TNF-α. The degradation of ECM is measured by the decrease in
concentration of SO4. The sulfite groups decorating the aggrecan proteins
are the groups that matter – the aggrecan protein is just an elaborate means
to keep sulfates in the solid phase and in place in the matrix (so-called
“fixed charges”). In an “sGAG” assay [18] there is an average of 30 gSO4/L
cartilage. The molecular weight of SO4 is 96 g/mol so that the molarity of
SO4 is
30 g/L
96 g/mol
= 0.3125 mol/L = 3125 micromolars/cm3.
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To obtain the parameter δU for ECM decay we note that the decay rate of
SO4 under one nanomolar of TNF-α is about 16% per week under 25 ng/ml
= 1.4706 nanomolar of TNF-α [24]. Then the decay modulus of SO4 is
−δU F
λF + F
= ln(1− 0.1/7)/day = −0.0144/day.
Using F = 1.4706 nM and λF = 0.5 nM we get δU = 0.0193/day.
For δF we have that the half life of TNF-α is around 100 hrs [30]. So
δF = − 24100 ln(12) = 0.1664 1day . For The coefficient δP , the half life of EPO is
around 30 hrs [17]. So δP = −2430 ln(12) = 0.5545 1day . For δM , the half life of
DAMPs is around 30 hrs [21]. So δM = −2430 ln(12) = 0.5545 1day . To obtain
decay rates from the experimental results in [21, 30], we used the “N-end
rule” [29].
For the coefficient δR, the natural half life of ROS is around 14 hrs at 0.1
nanomolar concentration. So δR = −2414 ln(12) = 1.1883 1day . However, under
the superoxide dismute SOD, the decay rate of ROS is almost immediately.
We don’t know when this reaction will happen. It is hard to measure here.
So we assume the coefficient δR = 60 in our model, which means the half life
of ROS is smaller than 20 mins.
To obtain the parameter σU for the release of DAMPs from ECM, we
assume 30 mg/cm3 of ECM (i.e., SO4) might release 10 ng/ml of DAMPs
when exposed to 25 ng/ml of TNF-α. To estimate the molecular weight
of DAMPs we consider the weight of one species, HMGB1, which has a
molecular weight of 29 kDA. Recall the source term for DAMPs is σUU
F
λF+F
.
Then
σUU
F
λF + F
= change rate of DAMPs = 10 ng/(cm3 · day)
=
10× 10−9g /cm3 · day
29000g/mol
= 0.3448× 10−9mol/(L · day).
Using U = 30 mg/cm3, F = 1.4706 nM and λF = 0.5 nM, we get
σU = 0.3448 · 0.7463/30× 10−9mol/L · day
mg/cm3
= 0.0154
nanomolar · cm3
mg · day .
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We need to reconcile the dimension to our model. The behavior of the
cartilage is sufficiently homogeneous at the top 1 cm layer that we can use
in the model the parameter σU = 0.0157
nanomolar·cm2
mg·day .
To obtain the parameter σR for the release of ROS from catabolic cells,
we assume 1-2% of oxygen consumed is converted to superoxides. Zhou et
al. [32] estimate the maximum oxygen consumption rate to be 10 nMoles per
million cells per hour in normal conditions (5%-21% oxygen). Then
σR =
0.01 · 10 nMoles
106 cells · h =
0.1 · 24 · 103
106
nMoles
L
cm3
day · cells .
Simplifying and assuming heterogeneity of the top layer, we get
σR = 0.0024
nanomolar · cm2
cells · day .
To obtain the parameter σF , we use that the release rate of TNF-α by
catabolic cells is 100 pg/ml · per 12 hr by 5× 104 cells/ml [28]. Then
σF =
100× 10−12 × 103g · (cm3/L)
5× 104 × 0.5× 17× 103(g/mol) · cells · day .
Simplifying and assuming heterogeneity of the top layer, we get
σF = 2.35 · 10−7 nanomolar · cm
2
cells · day .
To obtain the parameter σM , we use that the release rate of HMGB1 is
3 ng/ml · per day by 2× 105 cells/ml [28]. Then
σM =
3× 10−9 × 103g · (cm3/L)
2× 105 × 29× 103(g/mol) · cells · day .
Simplifying and assuming heterogeneity of the top layer, we get
σM = 5.17 · 10−7 nanomolar · cm
2
cells · day .
To obtain the parameter σP , we use that the release rate of EPO by
healthy cells is 18 ng/ml · per 4 days by 105 cells/cm2 [14]. Then
σP =
18× 10−9 × 103g · (cm3/L)
(105)
3
2 × 4× 34× 103(g/mol) · cells · day .
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Simplifying and assuming heterogeneity of the top layer, we get
σP = 4.2 · 10−5 nanomolar · cm
2
cells · day .
For σP we also conduct runs with a higher value corresponding to treatment
that increases EPO; this is not a “natural” production rate. We choose
σP = 0.0033, which is high enough to trigger the Heaviside functions in
the model so that P becomes larger than Pc and shuts off the inflammation
response.
The parameters KU and p0 are experimental settings [15]. Diffusion co-
efficients were obtained from measurements presented in [23], delays from
[14], and the remaining parameters were approximated. The parameters for
system (1) are summarized in Table 1.
2.3 Simulation results
We computed results of our system for four values of the strain,  = 0.3, 0.4,
0.6, and 0.8, crossed with two values of the EPO production parameter: a
“low” value of σP = 4.2 · 10−5 and a “high” value of σP = 3.3 · 10−3. The
low value corresponds to the parameter obtained from [14] in Section 2.2,
whereas the high value is set to trigger the Heaviside functions in our system
and can correspond, for example, to the effects of treatment. Extremal values
at t = 10 days of the system variables are presented in Tables 2 and 3 and
provide an overview of the behavior of entire system. We focus on simulations
results most relevant to understanding the inflammation process, namely the
spatial and temporal dynamics of the healthy, catabolic and EPOR-active
cell populations.
To more fully understand the changes in the system due to changes in
the strain, we present computational results for  = 0.4, 0.6, and 0.8 at
low EPO production in Figures 2-4. To understand the effects of increasing
EPO production, we present computational results for  = 0.6 at high EPO
production, noting that the responses at other strains are similar. Compu-
tational results for  = 0.6 at high EPO production are shown in Figure
5.
As expected, higher levels of strain result in lower levels of healthy cells
and a larger area of inflammation. Also as expected, elevated EPO levels
result in a check on the inflammation process. The dynamics in the ”penum-
bra”, the region of catabolic and EPOR-active cells, is perhaps the most
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insightful result, showing a preponderance of catabolic over EPOR-active
cells.
The success of our model in incorporating a relatively large number of ex-
perimentally measured parameters and obtaining results matching observed
inflammation response under our “low” EPO case validates the mechanistic
assumptions that went into our model. As such, we find from our simulation
results greater confidence that the model itself is a firm foundation for a truly
predictive model. More importantly at this stage of theoretical development,
the simulation results indicate that we have brought together disparate ex-
periments and piecemeal understandings of system components and formed a
more holistic understanding of articular cartilage lesion under cyclic loading.
For the ”high” EPO case, much more work remains to be done, both in
model refinement and validation. How one increases EPO or other chemicals
that act like EPO in the cartilage environment affects both model refinement
and model validation.
Although perhaps of less interest to a clinician, knowing the dynamics
of live cell subtypes within the penubra is an important means of validating
these results.
2.4 Numerical methodology
We first did a semi-discretization in space, using the radially symmetric finite
difference scheme presented in Appendix C of [2]. The semi-discrete system
of delay-differential equations was then solved in MATLAB by using dde23
[26]. This approach is suitable for the models in this paper and was also used
to solve the model equations in [20]. Computational convergence studies for
each dependent variable in system (1) are shown in Tables 4-7. The relative
errors found are well within experimental or real world measurement error,
are primarily due to tracking a sharp front, and there is no indication that
the computed solutions differ qualitatively from the true solutions.
3 Conclusions
In this paper we presented biomathematical models based on observations
of chondrocyte mechanotransduction. When run in concert with a finite ele-
ment program to incorporate the physical effects of mechanical compression,
our new model may prove to be useful for predicting the consequences of
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long-term exposure to the broad range stresses experienced by cartilage in
human joints. As such the model may be useful for identifying critical stress
thresholds that, over time, increase the risk for osteoarthritis.
We have demonstrated that using delay differential equations to model
the delays in the cellular responses to cytokines in articular cartilage lesion
formation is a reasonable approach for models with the complexity of those in
this paper. However, as model complexity increases, the use of delay differen-
tial equations will lead to computational challenges down the line due to the
need to keep in memory vast past history information. Adding somewhat to
these challenges is that the commercial off-the-shelf (COTS) solution, dde23
in Matlab, uses an explicit time integration method for the differential equa-
tions. The stability constraints introduced by the semi-discretization in space
force dde23 to take time steps much smaller than what truncation error alone
would dictate. This, in turn, exasperates the memory issues caused by the
need to store the past history of the system. Once solution may be to use
a different time discretization. However, even a “stiff” DDE solver for the
programming environment R was found not to be appreciably faster [27].
The limitations of using delay differential equations and the computa-
tional methods for them may be ameliorated by converting the delay into a
physiological property of individual cells, namely time since exposure to the
relevant cytokine. The partial differential equations for the cell populations
that result from this approach include an additional independent variable
and a derivative term for “age” structure. Essentially, one would be taking
the equivalent of a non-Markov process and converting it into the equivalent
of a Markov process. Although the addition of an extra dimension to the
problem may seem like an unwanted complication, the reality is that the
delays in a delay-differential equation require the retention of time histories
of the system that can quickly become much larger to store in memory than
the extra age dimension. This difference in cost is even more pronounced
if we use highly efficient methods for age- and space-structured problems
[3, 5, 9, 10]. These methods have a history of effective use in the model-
ing and simulation of biofilms [8, 11, 12, 22], avascular tumor invasion [13],
and Proteus mirabilis swarm colony development [4, 6, 7]. Using age struc-
ture to represent the delays in cellular responses to cytokines is an approach
suggested by our experiences with the simulations in this paper.
Despite the challenges the use of delay terms presents for computational
studies with greater complexity, the use of delays in the first efforts in [20] and
in this paper is warranted; we have the tautology that delay terms are more
12
easily understood to represent delays. Moreover, some modelers may find the
models with delays are better suited for inclusion in their own efforts. Other
modelers may find that the greater flexibility inherent in using “age”, or some
other physiologically structured variable, makes that approach preferable.
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Parameter Value Units Reason
DR 0.1
cm2
day
Determined from [23]
DM 0.05
cm2
day
Determined from [23]
DP 0.005
cm2
day
Determined from [23]
DF 0.05
cm2
day
Determined from [23]
δR 60
1
day
Approximated
δM 0.5545
1
day
Determined from [21]
δF 0.1664
1
day
Determined from [30]
δP 3.326
1
day
Taken from [17]
δU 0.0193
1
day
Determined from [24]
σR 0.0024
nanomolar·cm2
day·cells Determined from [32]
σM 5.17 · 10−7 nanomolar·cm2day·cells Determined from [28]
σF 2.35 · 10−7 nanomolar·cm2day·cells Determined from [28]
σP 4.2 · 10−5 or 0.0033 nanomolar·cm2day·cells Determined from [14]
σU 0.0154
nanomolar·cm2
day·mg Determined from [24]
Λ 0.5 nanomolar Approximated
λR 10 nanomolar Approximated
λM 0.5 nanomolar Approximated
λF 0.5 nanomolar Approximated
λP 0.5 nanomolar Approximated
λU 1 mg/cm
2 Approximated
KU 0.0545 proportion Experimental setting [15]
α 1 1
day
Approximated
β1 10
1
day
Approximated
β2 5
1
day
Approximated
γ 1 1
day
Approximated
ν 0.05 1
day
Approximated
p0 1
1
day
Experimental setting [15]
µSA 0.1
1
day
Approximated
µDN 0.05
1
day
Approximated
Pc 1 nanomolar Taken from [14]
τ1 0.5 day Taken from [14]
τ2 1 day Taken from [14]
Table 1: Parameter Values
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variable Strain=30% Strain=40% Strain=60% Strain=80%
C min 1.374 ×104 2.58×103 71.02 0
ST max 7.254×104 8.627×104 8.909 ×104 9.07 ×104
SA max 2.79×103 5.524 ×103 1.105 ×104 1.533 ×104
DA max 22 64 180 302
DN max 1.213 ×104 2.888 ×104 6.35 ×104 8.616 ×104
U min 29.933 29.894 29.862 29.824
F max 0.0257 0.0332 0.0411 0.0476
M max 0.0253 0.0428 0.0663 0.0744
P max 0.3234 0.3159 0.3038 0.3006
R max 2.7323 3.3031 3.479 3.493
Table 2: Table of variable ranges under low EPO production at t=10 days
variable Strain=30% Strain=40% Strain=60% Strain=80%
C min 8.029 ×104 5.74×104 1.01 ×104 0
ST max 4.778×103 7.527×103 2.78 ×104 9.022 ×104
SA max 21.29 38.28 118 355
DA max 0.099 0.39 1.648 7
DN max 1.213 ×104 2.887 ×104 6.35 ×104 8.616 ×104
U min 29.999 29.9988 29.9987 29.98
F max 0.0027 0.0037 0.005 0.0073
M max 0.0082 0.0168 0.0349 0.0411
P max 7.919 9.2917 13.718 21.28
R max 0.189 0.2967 0.5139 0.699
Table 3: Table of variable ranges under high EPO production at t=10 days
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variable Strain=30% Strain=40% Strain=60% Strain=80%
C 0.0242 0.0314 0.0244 0.0220
ST 0.0230 0.0225 0.0219 0.0212
SA 0.0383 0.0352 0.0304 0.0272
DA 0.0525 0.0460 0.0371 0.0318
DN 0.0000 0.0000 0.0000 0.0000
ECM 0.0000 0.0000 0.0000 0.0000
TNF-α 0.0224 0.0204 0.0204 0.0191
EPO 0.0240 0.0244 0.0319 0.0323
DAMPs 0.0219 0.0204 0.0184 0.0171
ROS 0.0230 0.0226 0.0838 0.1085
Table 4: ∞-norm relative errors under low EPO production
variable Strain=30% Strain=40% Strain=60% Strain=80%
C 0.0102 0.0132 0.0122 0.0110
SA 0.0140 0.0131 0.01237 0.0118
ST 0.0206 0.0186 0.0153 0.0134
DA 0.0261 0.0230 0.0180 0.0151
DN 0.0000 0.0000 0.0000 0.0000
ECM 0.0000 0.0000 0.0000 0.0000
TNF-α 0.0148 0.0122 0.0204 0.0114
EPO 0.0134 0.0144 0.0170 0.0175
DAMPs 0.0152 0.0137 0.0118 0.0107
ROS 0.0140 0.0133 0.0166 0.0235
Table 5: 2-norm relative errors under low EPO production
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variable Strain=30% Strain=40% Strain=60% Strain=80%
C 0.0006 0.0013 0.0045 0.0141
ST 0.0253 0.0305 0.0219 0.0420
SA 0.0375 0.0362 0.0304 0.0416
DA 0.0430 0.0588 0.0371 0.0559
DN 0.0000 0.0000 0.0000 0.0000
ECM 0.0000 0.0000 0.0000 0.0000
TNF-α 0.0213 0.0204 0.0203 0.0185
EPO 0.0249 0.0246 0.0306 0.0372
DAMPs 0.0188 0.0212 0.0220 0.0192
ROS 0.0253 0.0249 0.0743 0.1144
Table 6: ∞-norm relative errors under high EPO production
variable Strain=30% Strain=40% Strain=60% Strain=80%
C 0.0002 0.0003 0.0008 0.0015
SA 0.0138 0.0134 0.0127 0.0116
ST 0.0164 0.0158 0.0143 0.0119
DA 0.0191 0.0192 0.0200 0.0167
DN 0.0000 0.0000 0.0000 0.0000
ECM 0.0000 0.0000 0.0000 0.0000
TNF-α 0.0128 0.0115 0.0204 0.0104
EPO 0.0130 0.0126 0.0135 0.0158
DAMPs 0.0124 0.0120 0.0115 0.0105
ROS 0.0135 0.0132 0.0148 0.0247
Table 7: 2-norm relative errors under high EPO production
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Figure 1: Schmatic of the articular cartiage lesion formation process under
cyclic loading.
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Figure 2: The density of the healthy, catabolic and EPOR-active chondro-
cytes (C(r, t), ST (r, t), SA(r, t)) at t = 2, 4, 6, 8, 10 days with  = 0.4 and
σP = 4.2 · 10−5 (light strain with low EPO production).
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Figure 3: The density of the healthy, catabolic and EPOR-active chondro-
cytes (C(r, t), ST (r, t), SA(r, t)) at t = 2, 4, 6, 8, 10 days with  = 0.6 and
σP = 4.2 · 10−5 (medium strain with low EPO production).
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Figure 4: The density of the healthy, catabolic and EPOR-active chondro-
cytes (C(r, t), ST (r, t), SA(r, t)) at t = 2, 4, 6, 8, 10 days with  = 0.8 and
σP = 4.2 · 10−5 (heavy strain with low EPO production).
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Figure 5: The density of the healthy, catabolic and EPOR-active chondro-
cytes (C(r, t), ST (r, t), SA(r, t)) at t = 2, 4, 6, 8, 10 days with  = 0.6 and
σP = 3.3 · 10−3(medium loading with high EPO production).
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